These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1430 related items for PubMed ID: 19046932
41. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation. McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S. Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322 [Abstract] [Full Text] [Related]
42. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients. Sánchez-Pérez B, Aranda Narváez JM, Santoyo Santoyo J, Fernández-Aguilar JL, Suárez Muñoz MA, González-Sánchez AJ, Pérez Daga JA, Ramírez Plaza CP, Carrasco Campos J, Jiménez Mazure C, Becerra Ortíz R. Transplant Proc; 2008 Nov; 40(9):2994-6. PubMed ID: 19010171 [Abstract] [Full Text] [Related]
43. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation. Manga Sahin G, Sahin S, Kantarci G, Ergin H. Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159 [Abstract] [Full Text] [Related]
44. Expanding the criteria of renal kidneys for transplantation: use of donors with acute renal failure. Deroure B, Kamar N, Depreneuf H, Jacquet A, Francois H, Charpentier B, Rostaing L, Durrbach A. Nephrol Dial Transplant; 2010 Jun; 25(6):1980-6. PubMed ID: 20167568 [Abstract] [Full Text] [Related]
45. Stable long-term renal function after pediatric liver transplantation. Herlenius G, Hansson S, Krantz M, Olausson M, Kullberg-Lindh C, Friman S. Pediatr Transplant; 2010 May; 14(3):409-16. PubMed ID: 20331519 [Abstract] [Full Text] [Related]
46. [Association between diabetes mellitus and hepatitis C in kidney transplant patients]. López Hidalgo R, Gentil MA, Acosta D, Escobar MJ, Sánchez Ibáñez R, Astorga R. Nefrologia; 2004 May; 24(6):572-8. PubMed ID: 15683030 [Abstract] [Full Text] [Related]
47. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction? Frei U, Schindler R, Wieters D, Grouven U, Brunkhorst R, Koch KM. Nephrol Dial Transplant; 1995 May; 10(7):1206-11. PubMed ID: 7478125 [Abstract] [Full Text] [Related]
48. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M. Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805 [Abstract] [Full Text] [Related]
49. Chronic kidney disease after heart transplantation. Hamour IM, Omar F, Lyster HS, Palmer A, Banner NR. Nephrol Dial Transplant; 2009 May; 24(5):1655-62. PubMed ID: 19168463 [Abstract] [Full Text] [Related]
50. Course of glomerular filtration rate after renal transplantation and the influence of hypertension. Wigger M, Drückler E, Muscheites J, Stolpe HJ. Clin Nephrol; 2001 Dec; 56(6):S30-4. PubMed ID: 11770810 [Abstract] [Full Text] [Related]
51. Chronic renal dysfunction late after liver transplantation. Cohen AJ, Stegall MD, Rosen CB, Wiesner RH, Leung N, Kremers WK, Zein NN. Liver Transpl; 2002 Oct; 8(10):916-21. PubMed ID: 12360433 [Abstract] [Full Text] [Related]
52. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors. Bajjoka I, Hsaiky L, Brown K, Abouljoud M. Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842 [Abstract] [Full Text] [Related]
53. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J. Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421 [Abstract] [Full Text] [Related]
54. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Duffy JP, Kao K, Ko CY, Farmer DG, McDiarmid SV, Hong JC, Venick RS, Feist S, Goldstein L, Saab S, Hiatt JR, Busuttil RW. Ann Surg; 2010 Oct; 252(4):652-61. PubMed ID: 20881772 [Abstract] [Full Text] [Related]
55. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome. Watt KD, Lyden ER, Gulizia JM, McCashland TM. Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465 [Abstract] [Full Text] [Related]
56. Renal function in pediatric liver transplantation: a long-term follow-up study. Harambat J, Ranchin B, Dubourg L, Liutkus A, Hadj-Haïssa A, Rivet C, Boillot O, Lachaux A, Cochat P. Transplantation; 2008 Oct 27; 86(8):1028-34. PubMed ID: 18946339 [Abstract] [Full Text] [Related]
57. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. Orlando G, Manzia T, Baiocchi L, Sanchez-Fueyo A, Angelico M, Tisone G. Transpl Immunol; 2008 Nov 27; 20(1-2):43-7. PubMed ID: 18773958 [Abstract] [Full Text] [Related]
58. Renal dysfunction in liver transplant patients: comparing patients transplanted for liver tumor or acute or chronic disease. Aberg F, Koivusalo AM, Höckerstedt K, Isoniemi H. Transpl Int; 2007 Jul 27; 20(7):591-9. PubMed ID: 17425724 [Abstract] [Full Text] [Related]
59. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Delladetsima JK, Boletis JN, Makris F, Psichogiou M, Kostakis A, Hatzakis A. Liver Transpl Surg; 1999 Jul 27; 5(4):294-300. PubMed ID: 10388502 [Abstract] [Full Text] [Related]
60. Outcomes after lung transplantation in patients with chronic hepatitis C virus infection. Sahi H, Zein NN, Mehta AC, Blazey HC, Meyer KH, Budev M. J Heart Lung Transplant; 2007 May 27; 26(5):466-71. PubMed ID: 17449415 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]